Letcure Pharmaceuticals Private Limited
About Letcure Pharmaceuticals Private Limited
Data last updated:
Letcure Pharmaceuticals Private Limited is a private limited company based in Thane, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 11 September 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74999MH2018PTC313855. Its GSTIN is 27AADCL7022P1Z5 (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Vaibhav Pramod Pandey and Pramod Kumar Pandey.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 403 – A Wing Dwarika Co – O.Soc.North Canara Bank Lane Navghar Road Bhayander (East), Thane, Maharashtra, India – 401105.
As per the financials filed for FY 2025, the company reported a revenue of ₹36.71 Lakh, a growth of 7% compared to the previous year. For the same year it recorded a net loss of ₹4.68 Lakh (net margin -12.8%) and EBITDA of -₹3.42 Lakh (EBITDA margin -9.3%). Revenue has grown at a compounded annual rate (CAGR) of 8% over three years and 17% over five years.
Company details
Contact details
Letcure Pharmaceuticals Private Limited's registered office is in Thane, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address403 – A Wing Dwarika Co – O.Soc.North Canara Bank Lane Navghar Road Bhayander (East), Thane, Maharashtra, India – 401105
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Letcure Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Letcure Pharmaceuticals is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations |
To see the full business activity and turnover split of Letcure Pharmaceuticals Private Limited, buy the company report.
Financials of Letcure Pharmaceuticals Private Limited
FY 2025 filings availableLetcure Pharmaceuticals Private Limited reported revenue of ₹36.71 Lakh (up 7% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 17% over five years, including 7% growth in the latest year. EBITDA rose 56% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹3.42 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹4.68 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -9.3% | ||||
| Net Profit Margin | -12.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Letcure Pharmaceuticals Private Limited, buy the company report.
Board of directors of Letcure Pharmaceuticals Private Limited
Letcure Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vaibhav Pramod Pandey | Director | 11 Sep 2018 | 8 Years 1 Months | Current |
| Pramod Kumar Pandey | Director | 11 Sep 2018 | 8 Years 1 Months | Current |
Auditor
Letcure Pharmaceuticals Private Limited is audited by S B JAJOO & CO for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S B JAJOO & CO | FY 2021 | 125915W |
Shareholding
The shareholding of Letcure Pharmaceuticals Private Limited is on record for FY 2021, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2021 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Letcure Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Letcure Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Letcure Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Letcure Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AADCL7022P1Z5 | Maharashtra | Active | 03 Dec 2018 |
To see the full GST registrations and return filing status of Letcure Pharmaceuticals Private Limited, buy the company report.
Recent activity
Letcure Pharmaceuticals Private Limited has 4 board changes on record since 2018: 2 appointments and 2 cessations. The latest: Ashutosh Shyamdhar Tiwari ceased to be Director on 26 Oct 2024.
Frequently asked questions
Letcure Pharmaceuticals is an active private limited company based in Thane, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 11 September 2018 (8+ years old) and is registered under CIN U74999MH2018PTC313855.
Letcure Pharmaceuticals has 2 current directors:
- Vaibhav Pramod Pandey - Director
- Pramod Kumar Pandey - Director
The latest financial statements of Letcure Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Letcure Pharmaceuticals is 27AADCL7022P1Z5, registered in Maharashtra.
The CIN (Corporate Identification Number) of Letcure Pharmaceuticals is U74999MH2018PTC313855. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Letcure Pharmaceuticals was incorporated on 11 September 2018, making it 8+ years old. It is registered with the Registrar of Companies, Mumbai.
Ashutosh Shyamdhar Tiwari ceased to be Director on 26 Oct 2024. Jay Prakash Satydev Mishra ceased to be Director on 28 Feb 2024. Pramod Kumar Pandey was appointed as Director on 11 Sep 2018. Letcure Pharmaceuticals has 4 board changes on record in total.
The registered office of Letcure Pharmaceuticals is at 403 – A Wing Dwarika Co – O.Soc.North Canara Bank Lane Navghar Road Bhayander East, Thane, Maharashtra, India – 401105.
Letcure Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.
Letcure Pharmaceuticals can be reached at its registered office: 403 – A Wing Dwarika Co – O.Soc.North Canara Bank Lane Navghar Road Bhayander East, Thane, Maharashtra, India – 401105.